Skip to content

Insider · CIK 0001911369

Nickson Philip

Reports to the SEC for 1 company · BOSTON, MA

Transactions

10

Companies

1

Filings

7

CIK

0001911369

Forms 4 and 5

Insider transactions

10 trades
DateCompanyValue
2026-04-09GLUEMonte Rosa Therapeutics, Inc.S Sale−$103K
2026-01-05GLUEMonte Rosa Therapeutics, Inc.S Sale−$47.9K
2026-01-02GLUEMonte Rosa Therapeutics, Inc.A Award—
2026-01-02GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2025-01-02GLUEMonte Rosa Therapeutics, Inc.A Award—
2025-01-02GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2024-06-03GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2024-01-02GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2023-01-03GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2022-03-01GLUEMonte Rosa Therapeutics, Inc. · Stock Option (Right to Buy)A Award—

Recent filings

7

Companies

1

Address

MONTE ROSA THERAPEUTICS, INC. 321 HARRISON AVENUE, SUITE 900

BOSTON, MA, 02118